华兰生物
(002007)
| 流通市值：253.05亿 | | | 总市值：293.86亿 |
| 流通股本：15.74亿 | | | 总股本：18.27亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,378,886,377.05 | 1,798,197,926.21 | 867,612,696.57 | 4,379,196,621.38 |
| 营业收入 | 3,378,886,377.05 | 1,798,197,926.21 | 867,612,696.57 | 4,379,196,621.38 |
| 二、营业总成本 | 2,486,370,142.96 | 1,310,025,664.46 | 553,612,323.28 | 3,124,967,498.36 |
| 营业成本 | 1,429,887,222.67 | 852,704,797.25 | 379,309,429.12 | 1,688,240,780.68 |
| 税金及附加 | 29,569,149.05 | 18,377,625.38 | 8,384,548.4 | 38,345,990.56 |
| 销售费用 | 606,912,297.65 | 151,069,877.18 | 44,939,097.16 | 775,796,281.95 |
| 管理费用 | 186,141,562.82 | 126,062,364.68 | 54,147,464 | 296,249,466.25 |
| 研发费用 | 234,642,551.42 | 161,354,978.4 | 66,459,646.88 | 333,177,802.38 |
| 财务费用 | -782,640.65 | 456,021.57 | 372,137.72 | -6,842,823.46 |
| 其中:利息费用 | 6,387,108.39 | 5,494,257.26 | 2,739,142.52 | 12,946,391.85 |
| 其中:利息收入 | 7,372,471.51 | 4,955,816.03 | 2,399,982.27 | 20,429,035.28 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 17,337,962.29 | 12,504,878.82 | 5,452,133.52 | 32,940,014.29 |
| 加:投资收益 | 85,482,183.32 | 78,427,996.02 | 38,443,296.73 | 137,517,910.98 |
| 资产处置收益 | 500,095.9 | -21,450.45 | -15,663.82 | 78,661.39 |
| 资产减值损失(新) | 12,277,453.7 | 12,277,453.7 | 1,046,468.97 | -74,225,065.72 |
| 信用减值损失(新) | -12,607,418.2 | 34,568,937.15 | 32,636,845.67 | 5,593,005.97 |
| 其他收益 | 12,593,010.37 | 9,173,135.8 | 5,890,180 | 23,448,748.14 |
| 四、营业利润 | 1,008,099,521.47 | 635,103,212.79 | 397,453,634.36 | 1,379,582,398.07 |
| 加:营业外收入 | 423,838.59 | 220,548.37 | 7,715.21 | 3,248,126.52 |
| 减:营业外支出 | 36,109,120.64 | 23,879,654.13 | 12,888,031.45 | 44,217,846.75 |
| 五、利润总额 | 972,414,239.42 | 611,444,107.03 | 384,573,318.12 | 1,338,612,677.84 |
| 减:所得税费用 | 144,713,247.09 | 88,752,716.99 | 60,741,950.07 | 183,142,885.59 |
| 六、净利润 | 827,700,992.33 | 522,691,390.04 | 323,831,368.05 | 1,155,469,792.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 827,700,992.33 | 522,691,390.04 | 323,831,368.05 | 1,155,570,296.32 |
| 终止经营净利润 | - | - | - | -100,504.07 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 784,423,022.36 | 515,859,492.79 | 313,135,984.76 | 1,087,850,982.47 |
| 少数股东损益 | 43,277,969.97 | 6,831,897.25 | 10,695,383.29 | 67,618,809.78 |
| 扣除非经常损益后的净利润 | 742,438,601.83 | 484,042,073.21 | 299,741,568.52 | 981,029,919.44 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.43 | 0.28 | 0.17 | 0.6 |
| (二)稀释每股收益 | 0.43 | 0.28 | 0.17 | 0.59 |
| 九、综合收益总额 | 827,700,992.33 | 522,691,390.04 | 323,831,368.05 | 1,155,469,792.25 |
| 归属于母公司股东的综合收益总额 | 784,423,022.36 | 515,859,492.79 | 313,135,984.76 | 1,087,850,982.47 |
| 归属于少数股东的综合收益总额 | 43,277,969.97 | 6,831,897.25 | 10,695,383.29 | 67,618,809.78 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-28 | 2025-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |